Impact of Vaso-Occlusion and the Risk of End-Organ Damage in Pediatric Patients with Sickle Cell Disease
Description
-
The webinar recording will be available through December 31, 2020.
Launched during Sickle Cell Disease Awareness month, this free webinar hosted by Novartis is a Sickle Cell Disease awareness program with a focus on the pediatric patient population. The program is presented by two speakers and will include a patient and caregiver perspective on the disease burden and impact of SCD on their quality of life. Agenda topics include an overview of SCD, acute and chronic complications of SCD, cumulative impact of VO, VOCs and end-organ damage, disease burden for patients with sickle cell disease, importance of transition from pediatric to adult care, and patient/caregiver perspectives with panel questions for the patient and caregiver.
Learning Objectives:
- Unmet need in pediatrics with SCD in management of vaso-occlusion
- Cumulative damage of vaso-occlusion and VOCs, which starts early in life for a patient with SCD
- Vasculopathy in pediatrics
- Acute and chronic complications in pediatric SCD patients
- Long term impact of acute and chronic complications which may lead to end organ damage
- Impact on transition on healthcare resources utilization
- Patient/caregiver focus on burden of illness in SCD and impact on quality of life
Speakers:
Andrew Campbell, MD
Children's National Medical Center, George Washington University School of Medicine and Health SciencesAhmar U. Zaidi, MD
Children’s Hospital of MichiganWith patient and caregiver perspectives from Carla Lewis and Teonna Woolford.
Associations
-
- Details
- Categories: Webinar